Brain Injury

Brain Injury, Cannabis, Provider Research

Substance Misuse and TBI Recovery: Key Findings by Jacotte-Simancas et al. (2021)

Robert Yrshus / December 31, 2024

Introduction The intersection of traumatic brain injuries (TBIs) and substance misuse poses a significant challenge in clinical practice. Jacotte-Simancas and […]

Brain Injury, Cannabis, Patient Research

How Alcohol, Opioids, and Cannabis Impact Brain Injuries – Insights from Experts (2021) Introduction

Robert Yrshus / December 31, 2024

Introduction Traumatic brain injuries (TBIs) affect millions of people each year, and recovery can be challenging. A team of researchers,

Brain Injury, Ketamine, Provider Research

Revisiting Ketamine for Acute Severe TBI: New Insights by Godoy et al. (2021)

Robert Yrshus / December 31, 2024

Introduction Ketamine, a well-established NMDA receptor antagonist, has gained renewed interest for its neuroprotective and anti-inflammatory properties in managing severe

Brain Injury, Ketamine, Patient Research

Ketamine in Severe Brain Injury: A “Old Drug, New Hope” Study by Critical Care Experts (2021)

Robert Yrshus / December 31, 2024

Introduction Severe traumatic brain injury (TBI) can leave patients and their loved ones searching for the best possible treatments to

VitalPoint Technologies, Inc.

Disclaimer

None of the statements in this announcement or via any web sites linked herein have been evaluated by the FDA. Furthermore, none of the statements in this announcement or any web sites linked herein should be construed as dispensing medical advice or making claims regarding the cure of diseases. You should consult a licensed health care professional before starting any supplement, dietary, or exercise program, especially if you are pregnant or have any pre-existing injuries or medical conditions. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any diseases.